274 results on '"Chen, Shu G."'
Search Results
2. Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization
3. Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study
4. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
5. Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
6. Antibody to DNA Detects Scrapie but Not Normal Prion Protein
7. Different Patterns of Truncated Prion Protein Fragments Correlate with Distinct Phenotypes in P102L Gerstmann--Straussler--Scheinker Disease
8. Large-Scale Validation of Skin Prion Seeding Activity as a Biomarker for Postmortem Diagnosis of Creutzfeldt-Jakob Disease
9. Mechanisms of Phenotypic Heterogeneity in Human Prion Diseases
10. Inducible Overexpression of Wild-Type Prion Protein in the Muscles Leads to a Primary Myopathy in Transgenic Mice
11. Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans
12. Prion protein functions as a ferrireductase partner for ZIP14 and DMT1
13. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinsonʼs disease
14. Fatal Familial Insomnia and Familial Creutzfeldt-Jakob Disease: Different Prion Proteins Determined by a DNA Polymorphism
15. Assessing prion infectivity of human urine in sporadic Creutzfeldt-Jakob disease
16. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease
17. Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans.
18. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
19. Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions
20. Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
21. Alteration of substrate selectivity through mutation of two arginine residues in the binding site of amadoriase II from Aspergillus sp
22. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
23. Expression and structural characterization of the recombnant human doppel protein
24. Cloning of amadoriase I isoenzyme from Aspergillus sp.: evidence of FAD covalently linked to Cys342
25. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231
26. Advances in Prion Disease Surveillance
27. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats
28. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease
29. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans
30. The Parkinsonʼs disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activity
31. Gerstmann-Sträussler-Scheinker: A New Phenotype With 'Curly' PrP Deposits
32. Sporadic and familial CJD: classification and characterisation
33. Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
34. Aberrant metal binding by prion protein in human prion disease
35. Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia
36. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease
37. LRRK2 in Parkinson's disease and dementia with Lewy bodies
38. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer’s Disease
39. Characterization of Antibody Specific for Disease Associated Prion Protein
40. Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type
41. Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
42. Genetic influence on the structural variations of the abnormal prion protein
43. Regulation of DJ-1 by Glutaredoxin 1 in Vivo: Implications for Parkinson’s Disease
44. Vitamin B12modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
45. Gestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria: Results from the Kidney Early Evaluation Program (KEEP)
46. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease
47. Characterization of Prion Proteins
48. Selection and characterization of DNA aptamers against PrPSc
49. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease
50. Characterization of the Prion Protein in Human Urine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.